Artificial intelligence (AI) software company C3.ai (NYSE:AI) will be reporting earnings tomorrow afternoon. Here's what to look for.
Last quarter C3.ai reported revenues of $72.36 million, up 10.8% year on year, beating analyst revenue expectations by 1.1%. It was a mixed quarter for the company, with revenue narrowly topping analysts' expectations. However, gross margin missed and has generally been on a downward trend. Looking ahead, its full-year revenue guidance came in higher than Wall Street's estimates. However, the outlook for the full year operating loss is larger.
Is C3.ai buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting C3.ai's revenue to grow 19.1% year on year to $74.33 million, improving on the 7.1% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.18 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company only missed Wall St's revenue estimates once over the last two years, and has on average exceeded top line expectations by 1.9%.
Looking at C3.ai's peers in the data infrastructure segment, some of them have already reported Q2 earnings results, giving us a hint of what we can expect. Teradata (NYSE:TDC) delivered top-line growth of 5% year on year, beating analyst estimates by 0.4% and Elastic (NYSE:ESTC) reported revenues up 17.5% year on year, exceeding estimates by 2.2%. Teradata traded up 1.1% on the results, and Elastic traded up 15.8%.
Read the full analysis of Teradata's and Elastic's results on StockStory.
There has been positive sentiment among investors in the data infrastructure segment, with the stocks up on average 14.7% over the last month. C3.ai is up 12.5% during the same time, and is heading into the earnings with analyst price target of $27.3, compared to share price of $30.3.
The author has no position in any of the stocks mentioned.